LA
LMAT icon

Lindenwold Advisors’s LeMaitre Vascular LMAT Stock Holding History

Lindenwold Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,450
Closed -$206K – 115
2025
Q1 		$206K Sell
2,450
-330
-12% -$30.7K 0.11% 103
2024
Q4 		$256K Sell
2,780
-575
-17% -$55.3K 0.14% 104
2024
Q3 		$312K Buy
3,355
+15
+0.4% +$1.3K 0.16% 93
2024
Q2 		$275K Hold
3,340
– – 0.15% 91
2024
Q1 		$222K Buy
+3,340
New +$206K 0.12% 111
2023
Q3 		– Sell
-3,270
Closed -$220K – 115
2023
Q2 		$220K Buy
+3,270
New +$199K 0.13% 105

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Lindenwold Advisors's LMAT Position: Q2 2025 in Review

Lindenwold Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 2,450 shares — an estimated $206K sold.

Lindenwold Advisors first reported a position in LMAT in Q2 2023 and held it in 6 quarters. The position peaked at $312K in Q3 2024. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • Lindenwold Advisors reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
  • Lindenwold Advisors sold 2,450 LeMaitre Vascular shares in Q2 2025, an estimated $206K.
  • Lindenwold Advisors first reported a position in LeMaitre Vascular in Q2 2023 and held it in 6 quarters.
  • Lindenwold Advisors's LeMaitre Vascular position peaked at $312K in Q3 2024.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Lindenwold Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.